NPI Details
DR. Sarju Waghela, D.O is an internal medicine in Irving, TX with 21 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Sarju Waghela, D.O NPI is 1033377692. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: UNIVERSITY OF NORTH TEXAS HSC, COLLEGE OF OSTEOPATHIC MED
Graduation Year:2004
The provider's business location address is:
2001 N MACARTHUR BLVD
#630
IRVING, TX
ZIP 75061-256
Phone: (972) 256-3537
Fax: (972) 255-7916
The NPI 1033377692 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, iron sucrose, 1 mg (HCPCS:J1756)
- Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
- Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
- Blood test, clotting time (HCPCS:85610)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Injection, zoledronic acid, 1 mg (HCPCS:J3489)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Reticulated (young) platelet measurement (HCPCS:85055)
- Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
- Irrigation of implanted venous access drug delivery device (HCPCS:96523)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Unclassified drugs (HCPCS:J3490)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
- Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
- Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
- Ferritin (blood protein) level (HCPCS:82728)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
- Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
The enumeration date for this NPI number is 5/29/2008 and was last updated on 8/19/2014.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | M9076 | TEXAS | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 315747YTU3 | MEDICARE UPIN | TEXAS | |
| 2 | 204308502 | MEDICAID | TEXAS | |
| 3 | 8L17678 | MEDICARE PIN | TEXAS | |
| 4 | 204308501 | MEDICAID | TEXAS | |
| 5 | P00868149 | OTHER | TEXAS | RAILROAD MEDICARE |
| 6 | 204308503 | MEDICAID | TEXAS | |
| 7 | TXB118862 | MEDICARE PIN | TEXAS | |
